FibroGen Receives FDA Clearance to Proceed With Clinical Study of FG-3019 in DMD

"FG-3019 shows a positive effect on fibrosis in clinical studies of DMD patients, and inhibits or reverses the build-up of fibrosis in their skeletal muscle":Quite a milestone,this one.From the look of it,looks like a pretty effective approach to contain the vagaries of MD.Big up from DMD communities to all the medical professionals who have spent years of their lives trying to get us a product that will give us hope and lives to our sons.  

Views: 240

Reply to This

Replies to This Discussion

Another company willing to run trial on non ambulatory subjects. I hope they have PPMDs full support!

Reply to Discussion

RSS

Need help using this community site? Visit Ning's Help Page.

Members

Events

© 2019   Created by PPMD.   Powered by

Badges  |  Report an Issue  |  Privacy Policy  |  Terms of Service